Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan flag Japan · Delayed Price · Currency is JPY
3,800.00
-55.00 (-1.43%)
Aug 4, 2026, 10:03 AM JST

Kissei Pharmaceutical Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Kissei Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥4,833. The average 1-year stock price forecast is 27.19% higher than the current stock price, while the lowest is ¥4,100 (+7.89%) and the highest is ¥5,500 (+44.74%).

Price Target: ¥4,833 (+27.19%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥4,100¥4,833¥4,850¥5,500
Change+7.89%+27.19%+27.63%+44.74%
* Price targets were last updated on Jun 24, 2026.

Analyst Ratings

The average analyst rating for Kissei Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy112222
Buy222211
Hold222233
Sell000000
Strong Sell000000
Total556666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Mizuho Securities
No rating
Mizuho Securities
Hold
Maintains
¥4,200
HoldMaintains¥4,200+10.53%Jun 24, 2026
Unknown Analyst
Nomura
No rating
Nomura
Hold
Downgrades
¥5,600¥4,100
HoldDowngrades¥5,600¥4,100+7.89%Jun 5, 2026
Unknown Analyst
SBI Securities
No rating
SBI Securities
Hold
Maintains
¥3,760
HoldMaintains¥3,760-1.05%Jun 4, 2026
Jefferies
Jefferies
Buy
Maintains
¥5,400¥4,800
BuyMaintains¥5,400¥4,800+26.32%May 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
92.70B
from 97.41B
Decreased by -4.83%
Revenue Next Year
97.45B
from 92.70B
Increased by 5.12%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
65.38B67.49B75.58B88.33B97.41B92.70B
Revenue Growth
-5.31%3.23%11.98%16.87%10.28%-4.83%
Gross Profit
31.24B32.38B37.34B44.07B45.82B45.47B
Gross Margin
47.78%47.97%49.41%49.89%47.04%49.05%
Operating Income
-1.40B-1.14B4.02B5.77B-2.93B1.70B
Net Income
12.92B10.53B11.16B11.96B13.78B11.29B
Dividend / Share
56.0080.0082.00100.00120.00170.00
Dividend Growth
-42.86%2.50%21.95%20.00%41.67%
Free Cash Flow
3.84B-7.65B200.38M2.45B82.75M10.01B
No. Analysts
-----4
Financial currency is JPY.

Revenue Forecast

Revenue202720282029
High98.2B
Avg92.7B
Low88.7B

Revenue Growth

Revenue Growth202720282029
High
0.8%
Avg
-4.8%
Low
-8.9%

EPS Forecast

EPS202720282029
High-
Avg-
Low-

EPS Growth

EPS Growth20282029
High-
Avg-
Low-